IIP's Life Sciences Push, Cannabis Wins

Innovative Industrial Properties (IIP) reported Q3 earnings, marking a significant shift into life sciences with a $105M investment in IQHQ. This includes a $100M revolving credit facility and $5M in preferred stock, with another $165M committed through Q2 2027. IIP also secured a $100M revolver to support this move and strengthen their balance sheet. Revenues increased by 3% to $64.7M, while adjusted funds from operations remained stable at $48.3M or $1.71 per share. Liquidity stands at nearly $80M, with gross assets over $2.7B and low leverage at 13% debt to assets. Despite cannabis tenant issues, IIP won a key court ruling against PharmaCann in Illinois and repossessed four California properties. However, around 20% of annual base rent remains non-paying due to consolidations. IIP secured a major lease with Lila Sciences for 244,000 sq ft at IQHQs Cambridge site, indicating strong demand in AI biotech hubs like Boston and San Diego. Federal cannabis buzz is growing with Trumps support for rescheduling to Schedule III, potentially reducing taxes and tapping seniors as a fast-growing user group. IIPs diversification strategy positions them for accretive growth, combining cannabis resilience with life sciences upside, while their conservative balance sheet provides flexibility for future expansion. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/b4543bc977c880a7